Haptoglobin Genotype Is a Regulator of Reverse Cholesterol Transport in Diabetes In Vitro and In Vivo-Reference-Cited by-同舟云学术

Haptoglobin Genotype Is a Regulator of Reverse Cholesterol Transport in Diabetes In Vitro and In Vivo

Published:2006-12-08 Issue:12 Volume:99 Page:1419-1425
ISSN:0009-7330
Container-title:Circulation Research
language:en
Short-container-title:Circulation Research

Author:

Asleh Rabea¹,Miller-Lotan Rachael¹,Aviram Michael¹,Hayek Tony¹,Yulish Michael¹,Levy Joanne E.¹,Miller Benjamin¹,Blum Shany¹,Milman Uzi¹,Shapira Chen¹,Levy Andrew P.¹

Affiliation:

1. From the Rappaport Faculty of Medicine (R.A., R.M.-L., M.A., S.B., A.P.L.), Technion-Israel Institute of Technology, Haifa, Israel; Departments of Internal Medicine (T.H.) and Opthalmology (M.Y., B.M.), Rambam Medical Center, Haifa, Israel; Department of Hematology and Oncology (J.E.L.), Brigham and Women’s Hospital, Boston, Mass; and Clinical Research Unit (U.M., C.S.), Clalit Health Services, Haifa and Western Galilee, Israel.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology

Reference38 articles.

1. Haptoglobin: The Evolutionary Product of Duplication, Unequal Crossing Over, and Point Mutation

2. Haptoglobin Phenotype and Vascular Complications in Patients with Diabetes

3. Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes

4. Haptoglobin Genotype Is Predictive of Major Adverse Cardiac Events in the 1-Year Period After Percutaneous Transluminal Coronary Angioplasty in Individuals With Diabetes

5. Haptoglobin Type and 30-Day Mortality in Diabetic Individuals Presenting With Acute Myocardial Infarction

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haptoglobin phenotype and intensive glycemic control for coronary artery disease risk reduction in people with type two diabetes: The Veterans Affairs Diabetes Trial;American Journal of Preventive Cardiology;2024-06

2. Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study;Diabetes Care;2024-03-14

3. Intensive lifestyle intervention in type 2 diabetes and risk of incident coronary artery disease for the common haptoglobin phenotypes: the Look AHEAD study;Cardiovascular Diabetology;2024-02-24

4. Relationship Between Time‐Varying Achieved High‐Density Lipoprotein Cholesterol and Risk of Coronary Events Depends on Haptoglobin Phenotype Within the ACCORD Lipid Study;Journal of the American Heart Association;2023-10-03

5. Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemia;Journal of Clinical Lipidology;2023-09